Patent · US Revoked

Antibodies against human CSF-1R and uses thereof

US9951140B2 · kind B2 · utility

0Cited by
33References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 4, 2016
Grant dateApr 24, 2018
Priority date
Expiry dateOct 4, 2036

Classification

  • Technology area (CPC —)General

Abstract

The present invention relates to antibodies against human CSF-1R (CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.